Re-inventing tumor targeting
Thermosome is a drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy. At its core is a new tumor targeting concept, which allows for increased local drug concentrations to achieve improved clinical treatment efficacy.
Thermosome Announces Further Dose Escalation in Phase I Trial with Lead Program THE001
Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronchi, MD, to Clinical Advisory Board
17th Annual European Life Sciences CEO Forum
Feburary 28–29, 2024